Limbic encephalitis and related cortical syndromes (Q44187530)

30 November 2017

title

Limbic encephalitis and related cortical syndromes (English)

1 reference

30 November 2017

Ignacio Rubio-Agusti

1

1 reference

30 November 2017

Miguel Salavert

series ordinal

2

1 reference

30 November 2017

Luis Bataller

series ordinal

3

1 reference

30 November 2017

publication date

1 April 2013

1 reference

Current treatment options in neurology

30 November 2017

published in

1 reference

30 November 2017

volume

15

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

169-184

1 reference

Paraneoplastic syndromes of the CNS.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinical, Magnetic Resonance Imaging, and Electroencephalographic Findings in Paraneoplastic Limbic Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Limbic encephalitis and small cell lung cancer. Clinical and immunological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Neurosyphilis and paraneoplastic limbic encephalitis: important differential diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Human herpesvirus 6 limbic encephalitis after stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Screening for tumours in paraneoplastic syndromes: report of an EFNS task force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Immunomodulatory treatment trial for paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinical analysis of anti-Ma2-associated encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Amphiphysin autoimmunity: paraneoplastic accompaniments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Case records of the Massachusetts General Hospital. Case 27-2012. A 60-year-old woman with painful muscle spasms and hyperreflexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Voltage‐gated potassium channel antibodies in limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Morvan syndrome: clinical and serological observations in 29 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Isolated hemidystonia associated with NMDA receptor antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Analysis of relapses in anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Progress in the management of paraneoplastic neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Intravenous immunoglobulin therapy for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Immunomodulatory therapies in neurologic critical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Cancer incidence and risk factors after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Does rituximab increase the incidence of infectious complications? A narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Infectious complications associated with immunomodulating biologic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Rituximab-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-012-0212-7

Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23250843

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23250843

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11940-012-0212-7

1 reference

release_na27n7jw5ffrnoew53mevo2kcy

30 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/na27n7jw5ffrnoew53mevo2kcy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference